Trial Profile
Phase II trial of indolepropionic acid in patients with Alzheimer's disease.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2010
Price :
$35
*
At a glance
- Drugs Indolepropionic acid (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Therapeutic Use
- Sponsors Intellect Neurosciences
- 05 Dec 2008 New trial record.